CompuGroup Medical SE & Co. KGaA (COP.DE)
EUR 21.7
(0.37%)
EUR 21.7
(0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 179.52 Million | 145.02 Million | 165.27 Million | 149.93 Million | 110.49 Million | 136.34 Million |
| Net Income | 46.87 Million | 74.11 Million | 69.03 Million | 73.42 Million | 66.15 Million | 92.59 Million |
| Depreciation & Amortization | 115.79 Million | 112.32 Million | 110.71 Million | 75.7 Million | 62.85 Million | 44.6 Million |
| Deferred income taxes | -14.66 Million | 352 Thousand | -4.66 Million | 6.27 Million | 10.69 Million | -5.07 Million |
| Stock-based compensation | -7.03 Million | 2.64 Million | 5.71 Million | 5.88 Million | 3.89 Million | 95 Thousand |
| Change in working capital | -9.09 Million | -43.17 Million | 4.37 Million | -12.1 Million | -24.07 Million | -15.21 Million |
| Other non-cash items | 47.65 Million | -1.23 Million | -19.89 Million | 754 Thousand | -9.03 Million | 14.36 Million |
| Investing Cash Flow | -124.32 Million | -145.41 Million | -163.97 Million | -457.11 Million | -139.44 Million | -47.48 Million |
| Investments in PPE | -75.41 Million | -81.03 Million | -77.49 Million | -55.72 Million | -43.74 Million | -40.35 Million |
| Acquisitions | -50.23 Million | -64.72 Million | -93.75 Million | -398.91 Million | -94.35 Million | -4.59 Million |
| Investment purchases | -7.56 Million | -4.63 Million | -6.05 Million | -2.02 Million | - | - |
| Sales/Maturities of investments | - | 4.63 Million | 6.05 Million | 2.02 Million | - | - |
| Other Investing Activities | 1.32 Million | 349 Thousand | 7.27 Million | -2.47 Million | -1.35 Million | -2.53 Million |
| Financing Cash Flow | -80.68 Million | -16.35 Million | 30.15 Million | 338.07 Million | 49.67 Million | -93.41 Million |
| Debt repayment | -504.21 Million | -295.41 Million | -91.14 Million | -447.43 Million | -54 Million | -341.26 Million |
| Dividends payments | -26.11 Million | -26.11 Million | -26.36 Million | -24.2 Million | -24.41 Million | -17.4 Million |
| Common Stock Repurchased | - | -9.1 Million | -96.09 Million | 472.12 Million | -41.06 Million | -24.96 Million |
| Common Stock Issuance | - | - | 243.93 Million | 337.98 Million | 170.51 Million | 290.25 Million |
| Other Financing Activities | -4.54 Million | 314.27 Million | -179 Thousand | -400 Thousand | -1.35 Million | -30 Thousand |
| Accounts receivables | 11.11 Million | -46.58 Million | -21.71 Million | -34.24 Million | -3.45 Million | -6.79 Million |
| Accounts payables | -21.07 Million | 15.56 Million | 23.91 Million | 11.26 Million | 4.09 Million | -4.7 Million |
| Inventory | 10.58 Million | -8.78 Million | -2.28 Million | 9.49 Million | -6.23 Million | -7.07 Million |
| Other working capital | -30.79 Million | -3.36 Million | 4.45 Million | 1.37 Million | -18.46 Million | -8.14 Million |
| Cash at beginning of period | 90.51 Million | 107.34 Million | 75.91 Million | 46.35 Million | 25.3 Million | 30.36 Million |
| Cash at end of period | 64.46 Million | 90.51 Million | 107.34 Million | 75.91 Million | 46.35 Million | 25.3 Million |
| Capital Expenditure | -75.41 Million | -81.03 Million | -77.49 Million | -55.72 Million | -43.74 Million | -40.35 Million |
| Effect of forex changes on cash | -570 Thousand | -80 Thousand | -18 Thousand | -1.32 Million | 320 Thousand | -518 Thousand |
| Net cash flow / Change in cash | -26.05 Million | -16.82 Million | 31.43 Million | 29.56 Million | 21.04 Million | -5.06 Million |
| Free Cash Flow | 104.11 Million | 63.98 Million | 87.77 Million | 94.2 Million | 66.75 Million | 95.99 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 13.92 Million | 18.39 Million | -15.48 Million | 46.87 Million | 16.77 Million | 31.09 Million |
| Depreciation & Amortization | 28.45 Million | 26.51 Million | 36.63 Million | 115.79 Million | 26.75 Million | 26.09 Million |
| Deferred income taxes | -2.71 Million | 650 Thousand | -6.93 Million | -14.66 Million | 20 Thousand | 18 Thousand |
| Stock-based compensation | 348 Thousand | 348 Thousand | 320 Thousand | -7.03 Million | -1.02 Million | -6.94 Million |
| Change in working capital | -16.61 Million | 54.41 Million | -11.77 Million | -9.09 Million | -20.85 Million | -32.56 Million |
| Other non-cash items | -2.94 Million | 2.85 Million | 40.55 Million | 47.65 Million | 129 Thousand | 595 Thousand |
| Investing Cash Flow | -53.21 Million | -17.69 Million | -36.8 Million | -124.32 Million | -15.49 Million | -30.54 Million |
| Investments in PPE | -15.48 Million | -19.48 Million | -29.16 Million | -75.41 Million | -14.11 Million | -14.34 Million |
| Acquisitions | -36.43 Million | 1.65 Million | -8.64 Million | -50.23 Million | -1.44 Million | -16.28 Million |
| Investment purchases | - | -313 Thousand | -7.38 Million | -7.56 Million | -180 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | 180 Thousand | - |
| Other Investing Activities | -1.29 Million | -8.03 Million | 1.01 Million | 1.32 Million | 68 Thousand | 73 Thousand |
| Financing Cash Flow | 17.48 Million | -6.93 Million | -9.13 Million | -80.68 Million | 1.87 Million | 5.23 Million |
| Debt repayment | -89.78 Million | -6.28 Million | -476.72 Million | -504.21 Million | -33.98 Million | -2.24 Million |
| Dividends payments | -51.73 Million | - | - | -26.11 Million | - | -26.11 Million |
| Common Stock Repurchased | -13.98 Million | -654 Thousand | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -6.57 Million | - | 4.54 Million | -4.54 Million | 35.85 Million | 33.59 Million |
| Accounts receivables | 53.22 Million | -41.04 Million | 4.28 Million | 11.11 Million | 2.61 Million | 11.85 Million |
| Accounts payables | -20.76 Million | -665 Thousand | 13.68 Million | -21.07 Million | 2.24 Million | -2.59 Million |
| Inventory | -1.16 Million | 2.12 Million | 2.33 Million | 10.58 Million | 898 Thousand | 1.84 Million |
| Other working capital | -47.9 Million | -8.04 Million | -18.39 Million | -30.79 Million | -26.6 Million | -43.67 Million |
| Cash at beginning of period | 118.14 Million | 64.46 Million | 66.58 Million | 90.51 Million | 58.04 Million | 65.6 Million |
| Cash at end of period | 77.75 Million | 118.14 Million | 64.46 Million | 64.46 Million | 66.58 Million | 58.04 Million |
| Capital Expenditure | -15.48 Million | -19.48 Million | -29.16 Million | -75.41 Million | -14.11 Million | -14.34 Million |
| Effect of forex changes on cash | 844 Thousand | -520 Thousand | 503 Thousand | -570 Thousand | 361 Thousand | -547 Thousand |
| Net cash flow / Change in cash | -40.39 Million | 53.68 Million | -2.12 Million | -26.05 Million | 8.54 Million | -7.56 Million |
| Free Cash Flow | -20.99 Million | 59.34 Million | 14.13 Million | 104.11 Million | 7.68 Million | 3.95 Million |
ARTL
STGN
SLBEN
RLE
IDDWF
461030